| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Celldex Therapeutics, Inc. | Former Officer | Common Stock | 20,833 | $500,002 | $24.00 | 13 Nov 2025 | Direct |
| Celldex Therapeutics, Inc. | Former Officer | Incentive Stock Option | 7,875 | 13 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | 13 Nov 2025 | 7 | -$490,264 | 4 | Former Officer | 17 Nov 2025, 16:17 |
| CLDX | Celldex Therapeutics, Inc. | 13 Jun 2024 | 1 | $0 | 4 | SR. VP & CCO | 17 Jun 2024, 16:16 |
| CLDX | Celldex Therapeutics, Inc. | 03 Jun 2024 | 8 | -$311,813 | 4 | SR. VP & CCO | 05 Jun 2024, 16:05 |
| CLDX | Celldex Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | SR. VP & CCO | 20 Jun 2023, 16:19 |
| CLDX | Celldex Therapeutics, Inc. | 15 Aug 2022 | 3 | -$418,943 | 4 | SR. VP & CCO | 17 Aug 2022, 16:05 |
| CLDX | Celldex Therapeutics, Inc. | 16 Jun 2022 | 1 | $0 | 4 | SR. VP & CCO | 17 Jun 2022, 16:19 |
| CLDX | Celldex Therapeutics, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Sr. VP & CCO | 21 Jun 2021, 16:28 |